These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 30700130)

  • 1. Contact Activation Inhibitor and Factor XI Antibody, AB023, Produces Safe, Dose-Dependent Anticoagulation in a Phase 1 First-In-Human Trial.
    Lorentz CU; Verbout NG; Wallisch M; Hagen MW; Shatzel JJ; Olson SR; Puy C; Hinds MT; McCarty OJT; Gailani D; Gruber A; Tucker EI
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):799-809. PubMed ID: 30700130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial.
    Lorentz CU; Tucker EI; Verbout NG; Shatzel JJ; Olson SR; Markway BD; Wallisch M; Ralle M; Hinds MT; McCarty OJT; Gailani D; Weitz JI; Gruber A
    Blood; 2021 Dec; 138(22):2173-2184. PubMed ID: 34086880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
    Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D
    Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XI and contact activation as targets for antithrombotic therapy.
    Gailani D; Bane CE; Gruber A
    J Thromb Haemost; 2015 Aug; 13(8):1383-95. PubMed ID: 25976012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials.
    DeLoughery EP; Olson SR; Puy C; McCarty OJT; Shatzel JJ
    Semin Thromb Hemost; 2019 Jul; 45(5):502-508. PubMed ID: 31216587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans.
    Koch AW; Schiering N; Melkko S; Ewert S; Salter J; Zhang Y; McCormack P; Yu J; Huang X; Chiu YH; Chen Z; Schleeger S; Horny G; DiPetrillo K; Muller L; Hein A; Villard F; Scharenberg M; Ramage P; Hassiepen U; Côté S; DeGagne J; Krantz C; Eder J; Stoll B; Kulmatycki K; Feldman DL; Hoffmann P; Basson CT; Frost RJA; Khder Y
    Blood; 2019 Mar; 133(13):1507-1516. PubMed ID: 30692123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of contact-mediated activation of factor XI protects baboons against
    Silasi R; Keshari RS; Lupu C; Van Rensburg WJ; Chaaban H; Regmi G; Shamanaev A; Shatzel JJ; Puy C; Lorentz CU; Tucker EI; Gailani D; Gruber A; McCarty OJT; Lupu F
    Blood Adv; 2019 Feb; 3(4):658-669. PubMed ID: 30808684
    [No Abstract]   [Full Text] [Related]  

  • 8. Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates.
    Crosby JR; Marzec U; Revenko AS; Zhao C; Gao D; Matafonov A; Gailani D; MacLeod AR; Tucker EI; Gruber A; Hanson SR; Monia BP
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1670-8. PubMed ID: 23559626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI.
    Tucker EI; Marzec UM; White TC; Hurst S; Rugonyi S; McCarty OJ; Gailani D; Gruber A; Hanson SR
    Blood; 2009 Jan; 113(4):936-44. PubMed ID: 18945968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First randomized evaluation of safety, pharmacodynamics, and pharmacokinetics of BAY 1831865, an antibody targeting coagulation factor XI and factor XIa, in healthy men.
    Nowotny B; Thomas D; Schwers S; Wiegmann S; Prange W; Yassen A; Boxnick S
    J Thromb Haemost; 2022 Jul; 20(7):1684-1695. PubMed ID: 35490404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting factor XI and factor XIa to prevent thrombosis.
    Gailani D; Gruber A
    Blood; 2024 Apr; 143(15):1465-1475. PubMed ID: 38142404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Undergoing Central Line Placement: A Phase 2 Clinical Trial.
    Pfeffer MA; Kohs TCL; Vu HH; Jordan KR; Wang JSH; Lorentz CU; Tucker EI; Puy C; Olson SR; DeLoughery TG; Hinds MT; Keshari RS; Gailani D; Lupu F; McCarty OJT; Shatzel JJ
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):290-299. PubMed ID: 37970718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.
    Puy C; Tucker EI; Wong ZC; Gailani D; Smith SA; Choi SH; Morrissey JH; Gruber A; McCarty OJ
    J Thromb Haemost; 2013 Jul; 11(7):1341-52. PubMed ID: 23659638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery.
    Yamashita A; Nishihira K; Kitazawa T; Yoshihashi K; Soeda T; Esaki K; Imamura T; Hattori K; Asada Y
    J Thromb Haemost; 2006 Jul; 4(7):1496-501. PubMed ID: 16839345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow.
    Zilberman-Rudenko J; Itakura A; Wiesenekker CP; Vetter R; Maas C; Gailani D; Tucker EI; Gruber A; Gerdes C; McCarty OJ
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):510-7. PubMed ID: 26769048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
    Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
    Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factor XI as a novel target for antithrombotic treatment.
    Löwenberg EC; Meijers JC; Monia BP; Levi M
    J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factor XI vaccination: an alternative strategy to prevent thrombosis.
    Zhong C; Zhang L; Chen L; Deng L; Li R
    J Thromb Haemost; 2017 Jan; 15(1):122-130. PubMed ID: 27813324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates.
    Gruber A; Hanson SR
    Blood; 2003 Aug; 102(3):953-5. PubMed ID: 12689935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescent Activity-Based Probe To Image and Inhibit Factor XIa Activity in Human Plasma.
    Modrzycka S; Kołt S; Adams TE; Potoczek S; Huntington JA; Kasperkiewicz P; Drąg M
    J Med Chem; 2023 Mar; 66(6):3785-3797. PubMed ID: 36898159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.